Stage
Dead | DeadTotal Raised
$62.9MAbout Ciris Energy
Ciris Energy is focused on enhanced natural gas production from low rank coals worldwide. Ciris Energy uses scientific innovation to effectively harvest untapped energy resources that traditional methods leave behind. Ciris is developing two independent technologies to efficiently convert low-rank coals to natural gas. The first method, ISBC (In-situ Bioconversion process), is a natural process that activates indigenous microbes in coal seams. The second, ESBC (Ex-situ Bioconversion process), combines coal sizing and depolymerization technology with microbial bioconversion to generate methane and other chemicals from mined coal. Both methods reduce the cost of energy production and are environmentally friendly compared to traditional methods. By rejuvenating unproductive coal territories through proprietary technologies that stimulate and optimize natural occurring processes, Ciris Energy is leading the way to efficiently produce natural gas through clean and sustainable methods.
Expert Collections containing Ciris Energy
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Ciris Energy is included in 2 Expert Collections, including Renewable Energy.
Renewable Energy
2,920 items
Companies in the Renewable Energy space, including solar, wind, hydro, geothermal, and nuclear energy providers, as well as related software developers.
Oil & Gas Tech
730 items
Companies in the Oil & Gas Tech space, including those focused on improving operations across upstream, midstream, and downstream sectors, as well as those working on sustainable fuels.
Ciris Energy Patents
Ciris Energy has filed 12 patents.
The 3 most popular patent topics include:
- Chemical processes
- Industrial gases
- Papermaking

Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
2/9/2016 | 10/29/2019 | Chemical processes, Industrial gases, Synthetic fuel technologies, Fuel gas, Metal halides | Grant |
Application Date | 2/9/2016 |
---|---|
Grant Date | 10/29/2019 |
Title | |
Related Topics | Chemical processes, Industrial gases, Synthetic fuel technologies, Fuel gas, Metal halides |
Status | Grant |
Latest Ciris Energy News
Jul 27, 2013
By FinSMEs Ciris Energy , a Centennial, Colorado-based company focused on enhanced natural gas and chemical production from low rank coals worldwide, raised $25m in Series C financing in two separate transactions (of $10M and $15M). Asia Pacific Capital of Hong Kong invested in the company, which will use the funds to execute commercial projects beyond its current domestic activities. Founded in 2007 and led by Dr. Jay Short, CEO, and Greg Jenkins, COO, Ciris Energy proprietary technologies that stimulate and optimize natural occurring processes to rejuvenate unproductive coal territories and convert it into natural gas and chemicals. The company is currently operating its first-phase commercial ISBC plant in the Powder River Basin of Wyoming and is targeting initiation of a demonstration plant in 2014 for its ESBC process. FinSMEs
Ciris Energy Frequently Asked Questions (FAQ)
Where is Ciris Energy's headquarters?
Ciris Energy's headquarters is located at 9155 East Nichols Avenue, Centennial.
What is Ciris Energy's latest funding round?
Ciris Energy's latest funding round is Dead.
How much did Ciris Energy raise?
Ciris Energy raised a total of $62.9M.
Who are the investors of Ciris Energy?
Investors of Ciris Energy include Asia Pacific Capital, Braemar Energy Ventures, Rho Ventures, GE Energy Financial Services, Khosla Ventures and 3 more.
Who are Ciris Energy's competitors?
Competitors of Ciris Energy include Glori Energy and 2 more.
Compare Ciris Energy to Competitors
Pennsylvania is home to the continuum of the biosciences - basic research, emerging companies, mature industry and global pharmaceuticals. Through Pennsylvania Bio these organizations interact to create a vibrant community. It is through the interactivity of this continuum that bioscience companies are spawned, are able to attract experienced managers and a talented workforce, and are able to grow and partner for advancement. It's all part of the company's mission: to be the catalyst to ensure Pennsylvania is engaged in biosciences by developing a cohesive community that unites the region's biotechnology, pharmaceutical, research and financial strengths.
BioProtection Systems (BPSC) is a biotechnology company located in the Iowa State University Research Park in Ames, Iowa. The company is developing vaccine solutions to increase the United States' biodefense capabilities.
AthenaES specializes in the development and commercialization of advanced biotechnology-based products. Throughout its eleven year history, the company has maintained a broad perspective for applying its core competency, the use of proteins and enzymes for commercial applications, to develop products. As such, the company currently markets its products and services through two business units and maintains an exploratory R&D group. The Athena Enzyme Systems Group aims to provide specialty reagents and proteins for the production and recovery of recombinant proteins along with providing contract R&D services. Products include: Expression Media, Serum-free Media, Protein Refolding kits, and the PDQ Protease Assay. This business unit also aims to provide specialized contract research, development and manufacturing services for the production of recombinant proteins. The Athena Environmental Services Group designs, develops and manufactures environmentally responsible products. Products developed include: The Bilge Pill, a biodegradable cleaning product for the removal of oil in boat bilges, and a plant nutrient supplement used in hydroponics, hobby gardens and horticulture that replaces conventional fertilizers, and the Sting Thing, an enzyme-based invertebrate sting treatment product. More recently, this group developed and has introduced a water-soluble, reversible glue, MagiGlue. The Athena Exploratory Science Group has the mission to pursue research with the potential for commercial, environmental and social impact. These projects are far reaching in their scope and represent high risk, high-value projects.
CombiSep Inc. has merged with Advanced Analytical Technologies, Inc. (AATI). aims to provide separation systems for the pharmaceutical, biotechnology, and chemical industries to increase productivity in discovery, development, and quality control processes. The cePRO 9600 system is a multiplexed capillary electrophoresis (CE) instrument providing near universal UV absorbance detection and the capability to perform 96 CE separations in parallel, increasing sample throughput. This technology aims to provide the company's customers with a key scientific and business advantage over traditional serial-based analytical methods, and aims to allow for quicker decisions on time-to-market strategies.
BioSphere was born in 1998 as the biotechnology division of S.F.I.R. S.p.A. with the aim of diversifying the activities in the biotech sector, and in particular for the development of technologies for the conversion of sugars and by-products of the agro-food industry into added value products. In 2002 BioSphere became an independent company with the capital fully hold by S.F.I.R. SpA. Today, BioSphere develops its own R&D projects and offers to other companies an efficient and qualified outsourcing service.
Spreading innovation in the Nano- and Biotechnology fields - this is the aim of Tethis. The company are heading for this goal through a tri-fold market approach reflected by the three business units of Tethis: Tethis Systems, Tethis Technology Services and Tethis Research. Tethis Systems focuses on the design and sale of nanoparticle synthesis and nanocoating units allowing customers to develop their own nanotech-products in-house. Tethis Technology Services supports customers with nano - and biotech product development by technical consulting and by opening Tethis' platform technologies for services such as tailor-made coatings or nanopowder development. Tethis Research targets on the incorporation of nanotechnology in devices, for instance by the integration of nanotechnology, biotechnology and microfabrication. Many of the company's research projects are based on collaborations with industries, universities and research centers reflecting the company's motto "Integration through collaboration".n